Virpax Pharmaceuticals Inc
NASDAQ:VRPX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Virpax Pharmaceuticals Inc
NASDAQ:VRPX
|
US |
|
Q
|
Qingling Motors Co Ltd
F:QIN
|
CN |
|
Lake Winn Resources Corp
F:EE1A
|
CA |
|
G
|
Golden Entertainment Inc
F:GE6
|
US |
|
C
|
Cathay Pacific Airways Ltd
DUS:CTY
|
HK |
|
S
|
Solaria Energia y Medio Ambiente SA
LSE:0KCD
|
ES |
|
M
|
Magnum Goldcorp Inc
F:1CJB
|
CA |
|
A
|
Agilyx ASA
XMUN:5NQ
|
NO |
|
Neuca SA
F:7HD
|
PL |
|
Enerside Energy SA
F:9O8
|
ES |
|
Ryvu Therapeutics SA
F:9Y4
|
PL |
|
Stack Capital Group Inc
F:9W0
|
CA |
|
Frontier IP Group PLC
F:8WT
|
UK |
|
Critical Infrastructure Technologies Ltd
F:X9V
|
CA |
|
N
|
Nice Total Cash Management Co Ltd
KOSDAQ:063570
|
KR |
|
Japan Asset Marketing Co Ltd
TSE:8922
|
JP |
|
Esker SA
OTC:ESKEF
|
FR |
|
S
|
Summarecon Agung Tbk PT
XMUN:RZU
|
ID |
|
SJW Group
NASDAQ:HTO
|
US |
|
SkinBioTherapeutics PLC
F:5KW
|
UK |
Bankruptcy Probability
Virpax Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Virpax Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Virpax Pharmaceuticals Inc
NASDAQ:VRPX
|
256 USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
650.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
378.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
187.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
290.6B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Virpax Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Virpax Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.
